The HEP-OKS Study - Hemifield Eye Patching and Optokinetic Stimulation to Treat Hemispatial Neglect in Stroke Patients
Sponsored by University of Luebeck
About this trial
Last updated 11 years ago
Study ID
HEP-OKS-01
Status
Completed
Type
Interventional
Phase
Phase 3
Placebo
No
Accepting
18 to 90 Years
All
Not accepting
Healthy Volunteers
Trial Timing
Ended 11 years ago
What is this trial about?
Spatial neglect represents one of the major cognitive disorders following stroke.
Patients patients fail to be aware of objects or people to their left and orientate
instead to their right side. Enduring neglect has been found to be a poor prognostic
indicator for functional independence following stroke. Despite some promising
experimental accounts there are no established treatments for this condition.
The aim of this study is to test whether a combined treatment with hemifield eye patching
(HEP) and optokinetic stimulation (OKS) can permanently reduce neglect behaviour and
improve functional outcome in patients with hemispatial neglect following stroke.
The investigators hypothesise that the treatment with HEP and OKS will lead to a greater
reduction of neglect scoring in the neglect test battery as well as a greater improvement
in functional independence scores as compared to the spontaneous clinical course of the
usual-care control group.
What are the participation requirements?
Inclusion Criteria
- Right hemisphere stroke
- Spatial neglect as determined by pathological scores in at least two tests of a neglect test battery (Azouvi et al., JNNP, 2004)
- Age > 18 years old
- Informed consent signature
Exclusion Criteria
- Bilateral or previous unilateral stroke lesions
- Pre-existing neurodegenerative disease
- Inability to give informed consent